Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

Blood Cancer J. 2020 Oct 2;10(10):95. doi: 10.1038/s41408-020-00363-6.

Authors

Marcella A Tschautscher¹, Dragan Jevremovic², Francis K Buadi¹, Martha Q Lacy¹, Morie A Gertz¹, Angela Dispenzieri¹, Prashant Kapoor¹, David Dingli¹, Lisa Hwa¹, Amie Fonder¹, Miriam Hobbs¹, Suzanne Hayman¹, John Lust¹, Stephen J Russell³, Nelson Leung⁴, Ronald S Go¹, Yi Lin¹, Wilson Gonsalves¹, Taxiarchis Kourelis¹, Rahma Warsame¹, Robert A Kyle¹, S Vincent Rajkumar¹, Shaji Kumar⁵

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
² Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.
³ Division of Hematology and Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
⁴ Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
⁵ Division of Hematology, Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biopsy
Bone Marrow* / metabolism
Bone Marrow* / pathology
Humans
Multiple Myeloma* / metabolism
Multiple Myeloma* / pathology
Multiple Myeloma* / therapy
Remission Induction

Grants and funding

P50 CA186781/CA/NCI NIH HHS/United States